2022-11-23 • Dikemaskini
This week, the stock of AstraZeneca was one of the most traded instruments in FBS Trader! It was even more popular than the stock of Tesla. There has been news that grabbed the attention of traders this week. It’s also worth mentioning the earnings of a company coming out this Friday. What should you know ahead of it?
EPS = 0.62 (vs. 0.47 in Q3 2020)
Revenue = 9520 (vs. 6578 in Q3 2020)
The release of financial results is expected on November 12, at 13:45 GMT+2.
The destiny of the Anglo-Swedish drug giant has been complicated since the start of the Covid-19 pandemic. You may have heard of the news about the vaccine that causes blood clots. As the cases were linked to AstraZeneca’s vaccine, several countries restricted its use. Luckily for AstraZeneca, the European Medicines Agency (EMA) and the World Health Organization (WHO) both confirmed that the vaccine was safe and effective. The organizations said that the number of blood clots was extremely rare. Another challenging factor for the company this year was linked to the production problems. AstraZeneca cut its vaccine deliveries to the EU by half, reportedly due to problems at its plants and delayed testing of a batch of vaccines.
However, the company managed to stabilize its performance in 2021. Last week, it announced the creation of a new division for vaccines and antibody therapies. Vaccines are seen as not a traditional area for the company, so optimization of its structure certainly helps with business processes. Another positive news is the approval of the drug maker’s antibody cocktail against Covid-19 in Australia. Now, the mixture is awaiting a review by the European Medicines Agency.
The first half of the year was the golden time for the company. The Covid vaccine resulted in an outstanding improvement of AstraZeneca’s financial results making 9% out of +18% of the total revenue growth in the first half of the year.
Apart from the vaccine, AstraZeneca has been working on cancer drugs – Lynparza, Tagrisso, Imfinzi, and diabetes medicine. Their sales have been rapidly growing as well. Higher demand for Tagrisso in the United States amid the broad-based adjuvant therapy for treating lung cancer patients may improve the company’s financial results as well. Other medical treatments are also likely to have contributed to sales growth in the third quarter.
The stock of AstraZeneca has been moving within an uptrend. The breakout of the 9500 level will be crucial, as it will lead to the rise to July's all-time high of 10 088. If stock's price breaks below the support of 9240, it will indicate a bearish scenario with the next potential target of 9000.
Summing up, AstraZeneca has a great potential to post good financial results for the third quarter. Its business structure is accelerating and new facilities are developing. Also, it produces necessary drugs for the treatment of Covid-19 and other severe diseases. The demand for this medicine has been growing last quarter and it may attribute to the strong financial report on Friday. Follow the release on Friday at 13:45 GMT+2!
Coinbase (#COIN) menyaksikan hasilnya meningkat kepada $773 juta pada Q1 2024, peningkatan 23% daripada suku sebelumnya dan melepasi jangkaan penganalisis.
Saham-saham AS telah menunjukkan prestasi setengah tahun pertama yang terburuk dalam tempoh lebih 50 tahun kesan dari percubaan Fed untuk mengawal inflasi dan kebimbangan tentang kemelesetan.
Powell mahukan pendaratan yang lembut untuk inflasi, seperti yang dilakukan oleh Greenspan pada tahun 1994. Tetapi nampaknya dia akan menempuh satu pendaratan yang sukar.
Fed mengumumkan pada hari Rabu bahawa ia membiarkan kadar dasar tidak berubah pada 5…
Jepun melangkah lebih dekat kepada campur tangan mata wang dengan amaran terkuatnya apabila yen merosot ke paras paling lemah dalam kira-kira 34 tahun berbanding dolar…
Sentimen pasaran yang memulih pada pembukaan dagangan awal minggu semalam telah menukar semula haluan pergerakan USD…
FBS menyimpan rekod data anda untuk mengoperasikan laman web ini. Dengan menekan butang "Terima", anda menyetujui Polisi Privasi kami.
Permohonan anda telah diterima
Pengurus akan menghubungi anda dalam amsa terdekat
Permohonan panggil balik seterusnya untuk nombor telefon ini
boleh dilakukan dalam dalam
Jika anda mempunyai isu yang perlu disegerakan, sila hubungi kami menerusi
Live Chat
Masalah dalaman. Sila cuba sebentar lagi
Jangan bazir masa anda – pantau bagaimana NFP mempengaruhi dolar AS dan kaut keuntungan!
|
